1-2 of 2
Martin Hänggi
Close
Sort by
Journal Articles

MP0533: A Multispecific Darpin CD3 Engager Targeting CD33, CD123, and CD70 for the Treatment of AML and MDS Designed to Selectively Target Leukemic Stem Cells

Matteo Bianchi, Christian Reichen, Stefanie Fischer, Yvonne Grübler, Aline Eggenschwiler, Rajlakshmi Marpakwar, Thamar Looser, Patricia Spitzli, Christel Herzog, Denis Villemagne, Yvonne Kaufmann, Alienor Auge, Martin Hänggi, Waleed Ali, Tamara Lekishvili, Teresa Frasconi, Stephan Wullschleger, Christof Zitt, Marco Franchini, Amelie Croset, Randall Watson, Vladimir Kirkin, Ursina Luethi, Adrian Ochsenbein, Carsten Riether, Daniel Steiner, Nicolas Leupin, Anne Goubier
Journal: Blood
Blood (2022) 140 (Supplement 1): 2251–2252.
https://doi.org/10.1182/blood-2022-163075
Published: 2022
Journal Articles

Avidity-Engineered CD3 Engaging DARPin ® Targeting Three Tumor Associated Antigens Induce Strong and Specific T Cell Dependent Killing of AML Cells with Potential for Improved Safety

Matteo Bianchi, Nina Reschke, Christian Reichen, Stefanie Fischer, Yvonne Grübler, Aline Eggenschwiler, Jennifer Krieg, Kyriaki Ioannou, Simone Ragusa, Thamar Looser, Patricia Spitzli, Christel Herzog, Denis Villemagne, Yvonne Kaufmann, Mirela Matzner, Alienor Auge, Martin Hänggi, Waleed Ali, Marco Franchini, Vladimir Kirkin, Bernd Schlereth, Ursina Luethi, Adrian Ochsenbein, Carsten Riether, Daniel Steiner, Anne Goubier
Journal: Blood
Blood (2021) 138 (Supplement 1): 1164.
https://doi.org/10.1182/blood-2021-152790
Published: 2021